PET Imaging in Movement Disorders
نویسندگان
چکیده
منابع مشابه
Microglial Imaging in Movement Disorders With PK11195 PET
Activated m icroglia play a major role in the pathogenesis in neurological disorders. The transition of m icroglia from the normal resting state to the activated state is associated w ith an increased expression of receptors known as peripheral benzodiazepine binding sites, which are abundant on cells of mononuclear phagocyte lineage. PK11195 is a ligand which binds selectively to peripheral be...
متن کاملPET and movement disorders.
In this paper the use of PET for determining the patterns of disruption of both regional cerebral metabolism, and the pre- and post-synaptic dopaminergic systems, associated with movement disorders is reviewed. That the various akinetic-rigid syndromes result in distinctive PET findings is shown, making functional imaging valuable in their differential diagnosis. PET may also be useful for dete...
متن کاملImaging Psychogenic Movement Disorders
The neurobiological basis of psychogenic movement disorders (PMDs) has been elusive, and they remain difficult to treat. In the last few years, functional neuroimaging studies have provided insight into their pathophysiology and neural correlates. Here, we review the various methodological approaches that have been used in both clinical and research practice to address neural correlates of func...
متن کاملFDG-PET and molecular brain imaging in the movement disorders clinic.
Neurology 2012;79:1306–1307 In this issue of Neurology, Hellwig et al.1 present the results of a large single-center blinded prospective cohort study of consecutively recruited patients (original cohort n 107) with Lewy body disease (Parkinson disease [PD] or related dementias) and atypical parkinsonian syndromes (APS), including patients with progressive supranuclear palsy (PSP), multiple syst...
متن کاملMolecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.
In this article the role of molecular imaging with SPECT and PET in patients with movement disorders is reviewed. It is mentioned that SPECT and PET imaging with cocaine analogues ((123)I-beta-CIT,(123)I-FP-CIT, (18)F-DOPA), radioligands labeling the presynaptic dopamine transporters, is of value for the differentiation of patients with PD or Parkinson-plus syndromes with individuals with essen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Nuclear Medicine
سال: 2018
ISSN: 0001-2998
DOI: 10.1053/j.semnuclmed.2018.07.006